Free Trial

Rani Therapeutics (RANI) SEC Filings & 10K Form

$5.50
+0.38 (+7.42%)
(As of 05/31/2024 ET)

Recent Rani Therapeutics SEC Filings

DateFilerForm TypeView
05/30/2024
3:48 PM
IMRAN MIR A (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
7:00 AM
Rani Therapeutics (Filer)
Form DEF 14A
04/17/2024
7:01 AM
Rani Therapeutics (Filer)
Form DEFA14A
04/17/2024
7:02 AM
Rani Therapeutics (Filer)
Form ARS
03/22/2024
8:25 PM
McKinley Kate (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
8:00 PM
Rani Therapeutics (Issuer)
Sanford Svai S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
8:00 PM
Imran Talat (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
8:00 PM
Groen Eric (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
8:00 PM
Hashim Mir (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
4:30 PM
Rani Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2024
3:09 PM
Rani Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2024
7:10 AM
Rani Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2023
7:05 AM
Rani Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/08/2023
3:30 PM
Quiroga Cortes Isidoro Alfonso (Filed by)
Rani Therapeutics (Subject)
Form SC 13D/A
12/08/2023
3:31 PM
Rani Therapeutics (Subject)
South Lake One LLC (Filed by)
Form SC 13D/A
12/07/2023
4:18 PM
Imran Talat (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:00 AM
Imran Talat (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
7:00 AM
Imran Talat (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:05 PM
BUTEL JEAN LUC (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
7:00 AM
Nanavaty Maulik (Reporting)
Rani Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2023
3:15 PM
Rani Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/25/2023
7:03 AM
Rani Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
4:04 PM
Rani Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
3:05 PM
Rani Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:00 AM
Rani Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RANI) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners